RxDoctor Payments Data

Dana Johnson, NP

Adult Health · Raleigh, NCNPI 1316291057

Payments from drug & device makers

$718in general payments, 2019–2025

Across 40 payments — averaging $17.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$290
  • Viiv Healthcare Company$116
  • Nevro Corp.$58
  • E.r. Squibb & Sons, L.L.C.$50
  • Balt USA, LLC$40
  • AstraZeneca$34
  • plus $130 from 6 others

What the payments were for

  • Food & beverage$718100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$718 in reported general payments places this provider in the 55th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Medicare billing

Part B allowed, 2024
$2,106
Medicare patients
34
Services billed
36

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban24$14,015
FarxigaDapagliflozin Propanediol16$9,733
Prasugrel Hcl15$347
Losartan Potassium14$196
Atorvastatin Calcium32$177
Furosemide39$169
ClopidogrelClopidogrel Bisulfate26$142
Isosorbide Mononitrate ErIsosorbide Mononitrate14$127
Metoprolol Succinate20$122
Nitroglycerin18$70
Spironolactone14$31
Metoprolol Tartrate12$29

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$31$14,01524 claims
AstraZenecaFarxiga$34$9,73316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 614 adult health providers in North Carolina.

Other adult health in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →